These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19880272)

  • 1. Aspirin inhibits MMP-9 mRNA expression and release via the PPARalpha/gamma and COX-2/mPGES-1-mediated pathways in macrophages derived from THP-1 cells.
    Xue J; Hua YN; Xie ML; Gu ZL
    Biomed Pharmacother; 2010 Feb; 64(2):118-23. PubMed ID: 19880272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin inhibits MMP-2 and MMP-9 expressions and activities through upregulation of PPARalpha/gamma and TIMP gene expressions in ox-LDL-stimulated macrophages derived from human monocytes.
    Hua Y; Xue J; Sun F; Zhu L; Xie M
    Pharmacology; 2009; 83(1):18-25. PubMed ID: 18971601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin inhibits MMP-2 and MMP-9 expression and activity through PPARalpha/gamma and TIMP-1-mediated mechanisms in cultured mouse celiac macrophages.
    Yiqin Y; Meilin X; Jie X; Keping Z
    Inflammation; 2009 Aug; 32(4):233-41. PubMed ID: 19462226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of apolipoprotein A-I on matrix metalloproteinase-2 expression in vivo and in vitro.
    Wang W; Shi X; Yuan Y; Zhu H; Zhou W; Huang H; Feng M
    Acta Biochim Biophys Sin (Shanghai); 2013 Mar; 45(3):194-202. PubMed ID: 23299078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E2 is an enhancer of interleukin-1beta-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibroblasts.
    Kojima F; Naraba H; Sasaki Y; Beppu M; Aoki H; Kawai S
    Arthritis Rheum; 2003 Oct; 48(10):2819-28. PubMed ID: 14558087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of matrix metalloproteinase-3 and -13 synthesis induced by IL-1beta in chondrocytes from mice lacking microsomal prostaglandin E synthase-1.
    Gosset M; Pigenet A; Salvat C; Berenbaum F; Jacques C
    J Immunol; 2010 Nov; 185(10):6244-52. PubMed ID: 20943996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of COX-2, Prostaglandin E synthase-1 and prostaglandin E receptors in blood mononuclear cells and plaque of patients with carotid atherosclerosis: regulation by nuclear factor-kappaB.
    Gómez-Hernández A; Martín-Ventura JL; Sánchez-Galán E; Vidal C; Ortego M; Blanco-Colio LM; Ortega L; Tuñón J; Egido J
    Atherosclerosis; 2006 Jul; 187(1):139-49. PubMed ID: 16212965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase-12 gene regulation by a PPAR alpha agonist in human monocyte-derived macrophages.
    Souissi IJ; Billiet L; Cuaz-Pérolin C; Slimane MN; Rouis M
    Exp Cell Res; 2008 Nov; 314(18):3405-14. PubMed ID: 18823978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
    Bianchi A; Moulin D; Sebillaud S; Koufany M; Galteau MM; Netter P; Terlain B; Jouzeau JY
    Arthritis Res Ther; 2005; 7(6):R1325-37. PubMed ID: 16277686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsomal prostaglandin E synthase-1 deficiency is associated with elevated peroxisome proliferator-activated receptor gamma: regulation by prostaglandin E2 via the phosphatidylinositol 3-kinase and Akt pathway.
    Kapoor M; Kojima F; Qian M; Yang L; Crofford LJ
    J Biol Chem; 2007 Feb; 282(8):5356-66. PubMed ID: 17186945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and regulation of microsomal prostaglandin E synthase-1 in human osteoarthritic cartilage and chondrocytes.
    Li X; Afif H; Cheng S; Martel-Pelletier J; Pelletier JP; Ranger P; Fahmi H
    J Rheumatol; 2005 May; 32(5):887-95. PubMed ID: 15868626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin increases CD36, SR-BI, and ABCA1 expression in human THP-1 macrophages.
    Viñals M; Bermúdez I; Llaverias G; Alegret M; Sanchez RM; Vázquez-Carrera M; Laguna JC
    Cardiovasc Res; 2005 Apr; 66(1):141-9. PubMed ID: 15769457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of luteolin on COX-2 and mPGES-1 expression in LPS-induced RAW264.7 cells].
    Wang XG; Chen GY; Chen MP
    Zhong Yao Cai; 2007 Oct; 30(10):1263-6. PubMed ID: 18300499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase-dependent microsomal prostaglandin E synthase-1 expression in macrophages: role of TNF-α and the EP4 prostanoid receptor.
    Khan KM; Kothari P; Du B; Dannenberg AJ; Falcone DJ
    J Immunol; 2012 Feb; 188(4):1970-80. PubMed ID: 22227567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans.
    Cipollone F; Fazia M; Iezzi A; Ciabattoni G; Pini B; Cuccurullo C; Ucchino S; Spigonardo F; De Luca M; Prontera C; Chiarelli F; Cuccurullo F; Mezzetti A
    Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1259-65. PubMed ID: 15155382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of PGE2 and the cAMP signalling pathway in the up-regulation of COX-2 and mPGES-1 expression in LPS-activated macrophages.
    Díaz-Muñoz MD; Osma-García IC; Fresno M; Iñiguez MA
    Biochem J; 2012 Apr; 443(2):451-61. PubMed ID: 22268508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 15-deoxy-delta 12,14-prostaglandin J(2) inhibits the synthesis of the acute phase protein SIP24 in cartilage: Involvement of COX-2 in resolution of inflammation.
    Ulivi V; Cancedda R; Cancedda FD
    J Cell Physiol; 2008 Nov; 217(2):433-41. PubMed ID: 18615580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity.
    Cipollone F; Fazia M; Iezzi A; Pini B; Cuccurullo C; Zucchelli M; de Cesare D; Ucchino S; Spigonardo F; De Luca M; Muraro R; Bei R; Bucci M; Cuccurullo F; Mezzetti A
    Circulation; 2004 Mar; 109(12):1482-8. PubMed ID: 15037537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control.
    Cipollone F; Iezzi A; Fazia M; Zucchelli M; Pini B; Cuccurullo C; De Cesare D; De Blasis G; Muraro R; Bei R; Chiarelli F; Schmidt AM; Cuccurullo F; Mezzetti A
    Circulation; 2003 Sep; 108(9):1070-7. PubMed ID: 12912808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of GSK-3 reduces prostaglandin E2 production by decreasing the expression levels of COX-2 and mPGES-1 in monocyte/macrophage lineage cells.
    Noma T; Takahashi-Yanaga F; Arioka M; Mori Y; Sasaguri T
    Biochem Pharmacol; 2016 Sep; 116():120-9. PubMed ID: 27453433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.